Caption Management, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,559,439
+61.1%
200,700
+100.7%
0.02%
+33.3%
Q2 2023$968,000
-70.6%
100,000
-66.7%
0.02%
-71.9%
Q1 2023$3,288,000
+477.0%
300,000
+127.4%
0.06%
+700.0%
Q4 2022$569,808
-65.2%
131,900
-39.5%
0.01%
-63.6%
Q3 2022$1,637,000
+5.5%
218,000
+41.3%
0.02%
+4.8%
Q2 2022$1,551,000
-32.8%
154,322
-17.2%
0.02%
-25.0%
Q1 2022$2,307,000
-79.0%
186,289
-61.2%
0.03%
-77.4%
Q4 2021$10,968,000
+180.7%
479,655
+171.6%
0.12%
+175.6%
Q3 2021$3,908,000
-5.8%
176,600
-44.8%
0.04%
-16.7%
Q2 2021$4,148,000
+23.0%
320,000
+23.3%
0.05%
-26.0%
Q1 2021$3,371,000
-70.8%
259,500
-68.9%
0.07%
-72.2%
Q4 2020$11,527,000
-0.7%
833,400
+5.8%
0.26%
-3.0%
Q3 2020$11,605,000
+4.0%
787,900
+14.7%
0.27%
-27.0%
Q2 2020$11,160,000
+19.3%
686,757
+6.6%
0.37%
-29.9%
Q1 2020$9,352,000
-19.7%
644,300
+12.1%
0.53%
+35.3%
Q4 2019$11,642,000
+522.9%
574,600
+63.9%
0.39%
+303.1%
Q3 2019$1,869,000
+41.9%
350,600
+75.3%
0.10%
+47.0%
Q2 2019$1,317,000
+35.2%
200,000
+33.3%
0.07%
+22.2%
Q1 2019$974,000150,0000.05%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders